Correlation analysis of serum TSG-14 and CORS26 levels with diabetic retinopathy

Serum TSG-14 and CORS26 levels with diabetic retinopathy

  • Yuqing Wang 1. Ningde Clinical Medical College of Fujian Medical University; 2. Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine. 3. Department of Ophthalmology, Ningde Municipal Hospital.
  • Shuhua Lin Department of Ophthalmology, Ningde Municipal Hospital
  • Li Yuan Endocrinology Department, Xiangya Medical College of Central South University
  • Xiaojuan Gao 1. Ningde Clinical Medical College of Fujian Medical University. 2. Department of Rheumatology, Ningde Municipal Hospital Affiliated to Ningde Normal University.
  • Lingli Lin Department of Ophthalmology, Ningde Municipal Hospital
  • Xiaoqing Li Department of Ophthalmology, Ningde Municipal Hospital
  • Zhaode Zhang Ningde Clinical Medical College of Fujian Medical University
DOI: https://doi.org/10.5937/jomb0-64337
Keywords: TNF-stimulated gene 14 (TSG-14), Cartilage Oligomeric Matrix Protein Like 26 (CORS26), Type 2 diabetes, Diabetic retinopathy

Abstract


Objective To investigate the relationship between serum Cartilage Oligomeric Matrix Protein Like 26 (CORS26), TNF-stimulated gene 14 (TSG-14), and diabetic retinopathy (DR).

Methods 276 patients with type 2 diabetes mellitus (T2DM) who were admitted to our hospital between April 2023 and April 2025 participated in a single-center cross-sectional analysis. These patients were divided into a DR group (156 patients) and a non-DR group (120 patients) based on the diagnostic findings. A nonproliferative DR (NPDR) group comprising 98 individuals and a proliferative DR (PDR) group comprising 58 patients were divided from the DR group. The associations between the markers of glycolipid metabolism, TSG-14, and CORS26 were examined using the Pearson method. A logistic analysis was conducted to examine the variables influencing DR in individuals with type 2 diabetes. The diagnostic utility of serum TSG-14 and CORS26 for DR in T2DM patients was assessed using ROC curves.

Results The overall information for the two patient groups was similar. While the level of HDL-C was lower than that of the non-DR group, the levels of serum TSG-14, CORS26, TC, TG, LDL-C, and HOMA-IR were higher in the DR group (all P<0.05). The PDR group's serum levels of TSG-14 and CORS26 were higher than those of the NPDR group (both P<0.05). Serum TSG-14 and CORS26 had a negative connection with HDL-C and a positive correlation with TC, TG, LDL-C, and HOMA-IR (all P<0.001). In patients with type 2 diabetes, the logistic regression analysis revealed that the following risk factors were associated with the occurrence of DR: length of diabetes, TC, TG, LDL-C, HOMA-IR, TSG-14, and CORS26 (all P<0.05). Serum TSG-14 and CORS26 areas under the curve (AUCs) for diagnosing DR in patients with type 2 diabetes (T2DM) were 0.833, 0.832, and 0.918, respectively, according to the ROC curve. The AUC of the combined diagnosis was greater than that of TSG-14 or CORS26 alone (Z = 2.811, 2.827; P = 0.018, 0.015).

Conclusion The levels of serum TSG-14 and CORS26 are closely related to the occurrence of DR in patients with T2DM. Combined detection has certain clinical value for diagnosing DR in patients with T2DM.

References

1.Goldney J, Sargeant JA, Davies MJ. Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy. Diabetologia. 2023 Oct;66(10):1832-1845. doi: 10.1007/s00125-023-05988-3. Epub 2023 Aug 19. PMID: 37597048; PMCID: PMC10474214.
2.Song SH. Young-onset type 2 diabetes and retinopathy: evidence of an adverse phenotype. BMJ Open Diabetes Res Care. 2024 Jan 2;12(1):e003899. doi: 10.1136/bmjdrc-2023-003899. PMID: 38167607; PMCID: PMC10773418.
3.Yang S, Liu R, Xin Z, Zhu Z, Chu J, Zhong P, Zhu Z, Shang X, Huang W, Zhang L, He M, Wang W. Plasma Metabolomics Identifies Key Metabolites and Improves Prediction of Diabetic Retinopathy: Development and Validation across Multinational Cohorts. Ophthalmology. 2024 Dec;131(12):1436-1446. doi: 10.1016/j.ophtha.2024.07.004. Epub 2024 Jul 5. PMID: 38972358.
4.Gholami Chahkand MS, Esmaeilpour Moallem F, Qezelgachi A, Seifouri K, Pesaran Afsharian A, Sheikhzadeh F, Poursalehi A, Fani Sadrabadi FS, Saghab Torbati M, Ramezanzade M, Alishiri G, Ansari A, Zare Dehabadi E, Karimi Matloub S, Sheikh Z, Deravi N, Mehrtabar S, Chichagi F, Faal Hamedanchi N, Arzaghi M, Asadi M, Alsadat Dadkhah P, Ansari A. Lipoprotein (a) as a predictor of diabetic retinopathy in patients with type 2 diabetes: A systematic review. Diab Vasc Dis Res. 2023 Nov-Dec;20(6):14791641231197114. doi: 10.1177/14791641231197114. PMID: 38018132; PMCID: PMC10685788.
5.Li Y, Zhu L, Cai MX, Wang ZL, Zhuang M, Tan CY, Xie TH, Yao Y, Wei TT. TGR5 supresses cGAS/STING pathway by inhibiting GRP75-mediated endoplasmic reticulum-mitochondrial coupling in diabetic retinopathy. Cell Death Dis. 2023 Sep 1;14(9):583. doi: 10.1038/s41419-023-06111-5. PMID: 37658045; PMCID: PMC10474119.
6.Ntentakis DP, Correa VSMC, Ntentaki AM, Delavogia E, Narimatsu T, Efstathiou NE, Vavvas DG. Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review. Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):717-752. doi: 10.1007/s00417-023-06236-5. Epub 2023 Sep 20. PMID: 37728754.
7.Li Q, Wang P, Gong Y, Xu M, Wang M, Luan R, Liu J, Li X, Shao Y. α-Klotho prevents diabetic retinopathy by reversing the senescence of macrophages. Cell Commun Signal. 2024 Sep 26;22(1):449. doi: 10.1186/s12964-024-01838-w. PMID: 39327553; PMCID: PMC11426092.
8.Medina-Ramirez SA, Soriano-Moreno DR, Tuco KG, Castro-Diaz SD, Alvarado-Villacorta R, Pacheco-Mendoza J, Yovera-Aldana M. Prevalence and incidence of diabetic retinopathy in patients with diabetes of Latin America and the Caribbean: A systematic review and meta-analysis. PLoS One. 2024 Apr 4;19(4):e0296998. doi: 10.1371/journal.pone.0296998. PMID: 38574018; PMCID: PMC10994322.
9.Luo L, Cai Y, Jiang Y, Gong Y, Cai C, Lai D, Jin X, Guan Z, Qiu Q. Pipecolic acid mitigates ferroptosis in diabetic retinopathy by regulating GPX4-YAP signaling. Biomed Pharmacother. 2023 Dec 31;169:115895. doi: 10.1016/j.biopha.2023.115895. Epub 2023 Nov 18. PMID: 37984309.
10.Poráčová J, Nagy M, Mydlárová Blaščáková M, Konečná M, Sedlák V, Zahatňanská M, Kimáková T, Vašková H, Rybárová V, Majherová M, Uher I. Diabetes mellitus and its influence on the incidence and process of diabetic retinopathy. Cent Eur J Public Health. 2023 Dec;31(Suppl 1):S4-S9. doi: 10.21101/cejph.a7838. PMID: 38272471.
11.Zhai L, Lu J, Cao X, Zhang J, Yin Y, Tian H. Association Between the Variability of Glycated Hemoglobin and Retinopathy in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis. Horm Metab Res. 2023 Feb;55(2):103-113. doi: 10.1055/a-1931-4400. Epub 2022 Oct 12. PMID: 36223803.
12.Oganov AC, Seddon I, Zein M, Yazdanpanah G, Fonoudi H, Jabbehdari S. Composition of the gut microbiome, role of diet, lifestyle, and antioxidant therapies in diabetes mellitus and diabetic retinopathy. Eur J Ophthalmol. 2024 Mar;34(2):367-383. doi: 10.1177/11206721231174490. Epub 2023 May 7. PMID: 37150930.
13.Huang Y, Wang Z, Ye B, Ma JH, Ji S, Sheng W, Ye S, Ou Y, Peng Y, Yang X, Chen J, Tang S. Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids. J Transl Med. 2023 Jul 7;21(1):451. doi: 10.1186/s12967-023-04259-4. PMID: 37420234; PMCID: PMC10329333.
14.Hu G, Gu L, Wang R, Jian Q, Lv K, Xia M, Lai M, Shen T, Hu J, Yang S, Ye C, Zhang X, Wang Y, Xu X, Zhang F. Ethanolamine as a biomarker and biomarker-based therapy for diabetic retinopathy in glucose-well-controlled diabetic patients. Sci Bull (Beijing). 2024 Jun 30;69(12):1920-1935. doi: 10.1016/j.scib.2023.12.053. Epub 2024 Jan 2. PMID: 38423871.
15.Bhatta S, Pant N, Pant SR. Prevalence of Diabetes and Diabetic Retinopathy in Far-western Province of Nepal. J Nepal Health Res Counc. 2023 Jul 20;20(4):875-880. doi: 10.33314/jnhrc.v20i4.4225. PMID: 37489670.
16.Wen X, Ng TK, Zhang G, Chen H, Wu Z, Liu Q, Zhang M. Tear lactate improves the evaluation of proliferative diabetic retinopathy in type-2 diabetes patients. Mol Biomed. 2025 Jul 18;6(1):52. doi: 10.1186/s43556-025-00297-0. PMID: 40676452; PMCID: PMC12270997.
17.Wang Q, Cheng H, Jiang S, Zhang L, Liu X, Chen P, Liu J, Li Y, Liu X, Wang L, Li Z, Cai G, Chen X, Dong Z. The relationship between diabetic retinopathy and diabetic nephropathy in type 2 diabetes. Front Endocrinol (Lausanne). 2024 Jan 26;15:1292412. doi: 10.3389/fendo.2024.1292412. PMID: 38344659; PMCID: PMC10853456.
18.Maurissen TL, Spielmann AJ, Schellenberg G, Bickle M, Vieira JR, Lai SY, Pavlou G, Fauser S, Westenskow PD, Kamm RD, Ragelle H. Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip. Nat Commun. 2024 Feb 14;15(1):1372. doi: 10.1038/s41467-024-45456-z. PMID: 38355716; PMCID: PMC10866954.
19.Seyyar SA, Tıskaoğlu NS, Onder Tokuc E, Mercanlı M, Doğan L. Is serum vitamin D associated with diabetic retinopathy and its severity or with diabetes itself ? Clin Exp Optom. 2023 Aug;106(6):612-618. doi: 10.1080/08164622.2022.2090232. Epub 2022 Jul 3. PMID: 35786311.
20.Attrill E, Richards SM, Ross RM, Sutherland BA, Premilovac D. Induction of Type 2 Diabetes in Mice to Understand Vascular Changes That Drive Diabetic Retinopathy. Methods Mol Biol. 2023;2678:1-12. doi: 10.1007/978-1-0716-3255-0_1. PMID: 37326701.
21.Oktem EO, Sayman D, Ayyildiz S, Oktem Ç, Ipek L, Ayyildiz B, Aslan F, Altindal EU, Yagci N, Dikici R, Karaca R, Cankaya Ş, Avnioglu S, Velioglu HA, Yulug B. Cognitive Function Deficits Associated With Type 2 Diabetes and Retinopathy: Volumetric Brain MR Imaging Study. Brain Behav. 2025 Mar;15(3):e70387. doi: 10.1002/brb3.70387. PMID: 40022286; PMCID: PMC11870829.
22.Yao X, Zhao Z, Zhang W, Liu R, Ni T, Cui B, Lei Y, Du J, Ai D, Jiang H, Lv H, Li X. Specialized Retinal Endothelial Cells Modulate Blood-Retina Barrier in Diabetic Retinopathy. Diabetes. 2024 Feb 1;73(2):225-236. doi: 10.2337/db23-0368. PMID: 37976214.
23.Widyaputri F, Khong EWC, Rogers SL, Nankervis AJ, Conn JJ, Sasongko MB, Shub A, Fagan XJ, Guest D, Symons RCA, Lim LL. Progression of diabetic retinopathy in women with pregestational diabetes during pregnancy and postpartum. Clin Exp Ophthalmol. 2024 Sep-Oct;52(7):761-773. doi: 10.1111/ceo.14410. Epub 2024 Jun 19. PMID: 38895754.
24.Yang Z, Liu Q, Wen D, Yu Z, Zheng C, Gao F, Chen C, Hu L, Shi Y, Zhu X, Liu J, Shao Y, Li X. Risk of diabetic retinopathy and retinal neurodegeneration in individuals with type 2 diabetes: Beichen Eye Study. Front Endocrinol (Lausanne). 2023 May 3;14:1098638. doi: 10.3389/fendo.2023.1098638. PMID: 37206443; PMCID: PMC10191177.
Published
2026/04/21
Issue
Ahead of print
Section
Original paper

Copyright (c) 2026 Yuqing Wang, Shuhua Lin, Li Yuan, Xiaojuan Gao, Lingli Lin, Xiaoqing Li, Zhaode Zhang

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.